Schmid M, Janssen K, Dockhorn-Dworniczak B, Metze D, Zelger B W, Luger T A, Schmid K W
Clinic of Dermatology, University of Münster, Germany.
Virchows Arch. 1997 Mar;430(3):233-7. doi: 10.1007/BF01324807.
The aim of the present study was to assess a possible role of the tumour suppressor gene p53 in neuroendocrine (Merkel cell) carcinoma of the skin with regard to tumour development and tumour progression. p53 was investigated in a series of routinely processed Merkel cell carcinomas, with application of four different p53 antibodies (CM-1, PAb1801, DO7, and PAb240) to 25 carcinomas and screening for p53 mutations of exons 4-8 by single-strand conformation polymorphism (SSCP) analysis in 9 cases. All 25 tumours in the present series showed the characteristic microscopic and immunohistochemical features of Merkel cell carcinoma of the skin. In 5 of the 25 Merkel cell carcinomas investigated 5-10% of tumour cell nuclei showed a positive p53 reaction with at least one anti-p53 antibody. A few scattered p53 positive nuclei were found in an additional 9 cases. The remaining 11 cases completely lacked p53 immunostaining. SSCP analysis of exons 4-8 revealed no significant alterations in the mobility shift of the single strand DNAs in the five cases with 5-10% p53-immunoreactive tumour nuclei or in five cases lacking p53 accumulation significant. Our results suggest that alterations of the p53 gene play only a minor part in the development or progression of Merkel cell carcinoma of the skin.
本研究的目的是评估肿瘤抑制基因p53在皮肤神经内分泌(默克尔细胞)癌的肿瘤发生和肿瘤进展方面可能发挥的作用。在一系列常规处理的默克尔细胞癌中对p53进行了研究,应用四种不同的p53抗体(CM-1、PAb1801、DO7和PAb240)检测25例癌组织,并对9例癌组织通过单链构象多态性(SSCP)分析筛查外显子4-8的p53突变。本系列中的所有25个肿瘤均表现出皮肤默克尔细胞癌的特征性显微镜和免疫组化特征。在25例接受研究的默克尔细胞癌中,有5例肿瘤细胞核中有5%-10%对至少一种抗p53抗体呈p53阳性反应。另外9例中发现有少数散在的p53阳性细胞核。其余11例完全缺乏p53免疫染色。外显子4-8的SSCP分析显示,在5例p53免疫反应性肿瘤细胞核占5%-10%的病例或5例无明显p53积聚的病例中,单链DNA的迁移率没有显著改变。我们的结果表明,p53基因改变在皮肤默克尔细胞癌的发生或进展中仅起次要作用。